<img alt="" height="1" width="1" />
No heart risk seen with Pfizer COPD drug -FDA
WASHINGTON, Jan 14 (Reuters) - US health officials on Thursday said they found no increased risk of heart trouble with use of Pfizer Inc&#39;s (PFE.N) inhaled lung drug Spiriva. The US Food and Drug Administration, in a statement, said it had finished ...
FDA Finds No Increased Stroke Risk With SpirivaWall Street Journal
Leading COPD Drug Won&#39;t Harm Heart: FDAPalm Beach Post
FDA finds no heart risk with Spiriva inhalerBusinessWeek
MedPage Today -Bioscience Technology -Drug Store News (blog)
all 107 news articles &raquo;